A simple whole-blood test for detecting antibodies to human immunodeficiency virus. 1998

W Schramm, and S E Wade, and G Barriga Angulo, and P Castillo Torres, and A Burgess-Cassler
Saliva Diagnostic Systems, Inc., Vancouver, Washington 98682-2444, USA.

We developed an immunochromatographic whole-blood test (WBT) which detects antibodies to human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) from fingerstick blood. The sensitivity and specificity of the WBT were 99.41% (1,018 confirmed positive patients) and 99.89% (941 uninfected patients), respectively (enzyme immunoassay [EIA] on serum or plasma as a reference). WBT performance was comparable to those of licensed EIAs and Western blotting, using 18 HIV-2 sera, 23 HIV-1 seroconversion panels, and a low-titer performance panel (in lieu of whole blood).

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012698 Serologic Tests Diagnostic procedures involving immunoglobulin reactions. Serodiagnosis,Serologic Test,Serological Tests,Test, Serologic,Tests, Serologic,Serodiagnoses,Serological Test,Test, Serological,Tests, Serological
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

W Schramm, and S E Wade, and G Barriga Angulo, and P Castillo Torres, and A Burgess-Cassler
July 1999, Clinical and diagnostic laboratory immunology,
W Schramm, and S E Wade, and G Barriga Angulo, and P Castillo Torres, and A Burgess-Cassler
May 1987, The Journal of infectious diseases,
W Schramm, and S E Wade, and G Barriga Angulo, and P Castillo Torres, and A Burgess-Cassler
January 1986, Diagnostic immunology,
W Schramm, and S E Wade, and G Barriga Angulo, and P Castillo Torres, and A Burgess-Cassler
July 1990, Clinical chemistry,
W Schramm, and S E Wade, and G Barriga Angulo, and P Castillo Torres, and A Burgess-Cassler
October 1989, Journal of clinical microbiology,
W Schramm, and S E Wade, and G Barriga Angulo, and P Castillo Torres, and A Burgess-Cassler
May 1991, Journal of virological methods,
W Schramm, and S E Wade, and G Barriga Angulo, and P Castillo Torres, and A Burgess-Cassler
August 1993, The Journal of pediatrics,
W Schramm, and S E Wade, and G Barriga Angulo, and P Castillo Torres, and A Burgess-Cassler
January 1988, Transfusion,
W Schramm, and S E Wade, and G Barriga Angulo, and P Castillo Torres, and A Burgess-Cassler
August 2003, The Medical journal of Malaysia,
W Schramm, and S E Wade, and G Barriga Angulo, and P Castillo Torres, and A Burgess-Cassler
June 1993, Archives of family medicine,
Copied contents to your clipboard!